No Prescription |
 |
 | ||
|
Apo Thiamine Thiamilate |
|
| ||
No Prescription » Prescription Drugs 2 » Apo Thiamine Thiamilate Thiamine (vitamin B1) is used to prevent or treat low levels of vitamin B1 in people who do not get enough of the vitamin from their diets. Most people who eat a normal diet do not need extra vitamin B1. However some conditions (such as alcoholism cirrhosis stomach/intestinal problems) can cause low levels of vitamin B1. Vitamin B1 plays an important role in the body. It is needed to maintain the health of the nerves and the heart. Low levels of vitamin B1 may cause heart failure and mental/nerve problems.How to use Thiamine HCl OralTake this vitamin by mouth with or without food usually 1 to 3 times daily. Follow all directions on the product package or take as directed by your doctor. If you are uncertain about any of the information consult your doctor or pharmacist.Dosage is based on your medical condition and response to treatment.Use this vitamin regularly to get the most benefit from it. To help you remember take it at the same time(s) each day. Buy Apo Thiamine Thiamilate and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Apo Thiamine Thiamilate: Product Type: Prescription Drugs 2 Apo-Thiamine ( Thiamilate Generic Thiamine (Vitamin B1) ) Apo-Thiamine (Thiamilate Generic Thiamine) Thiamilate Generic Thiamine 50mg 100 Tablets 400 Tablets 200 Tablets Thiamilate Generic Thiamine Apo-Thiamine
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
